PSID - News..Revolutionary Glucose Breath Test Attracting Potential Partners marketwire
Press Release Source: BiomedReports On Tuesday May 4, 2010, 3:10 pm
LOS ANGELES, CA--(Marketwire - 05/04/10) - PositiveID Corporation (NASDAQ:PSID - News) is developing the non-invasive Easy Check breath glucose analysis system and sources are telling BioMedReports that a bigger company or two have taken an interest in partnering with them for a piece of the huge diabetic market that the test would open up.
As reported earlier, this unique, non-invasive glucose detection system measures the levels of acetone in a diabetic patient's exhaled breath.
It combines a proprietary chemical mixture with exhaled breath, which creates a new molecular compound that can be measured with the Company's patent-pending technology.
Industry sources say a significant partnership may be very close to completion and public announcement. Such news would not only help validate the technology, but would also likely send PSID's tightly floated shares upward.
In the U.S. alone, 23.6 million people (7.8% of the total population) have diabetes. The PSID device could eliminate a patient's need to prick his or her finger multiple times per day to get a blood sugar reading.
BioMedReports.com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report news and developments about publicly traded companies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.